The Relationship between the Items of the Barthel Index and Short-Term Prognosis in Terminal Cancer Patients
by
, and
Shinya Okamoto
1, 
Kazuko Okazaki
1,
Masahiro Okada
1,*,
Fumiyoshi Murakami
1,
Hiroki Sugihara
1,
Yoshinori Hoshino
1,
Yuka Ogawa
1,
Kengo Banshoya
2,
Eisuke Takei
1,
Shuso Takeda
2 and
Narumi Sugihara
2 1
Department of Pharmacy Onomichi Municipal Hospital, 3–1170–177 Shintakayama, Onomichi 722-8503, Japan
2
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzou 1, Hiroshima 729-0292, Japan
*
Author to whom correspondence should be addressed.
Reports 2023, 6(1), 5; https://doi.org/10.3390/reports6010005
Submission received: 9 December 2022
/
Revised: 20 January 2023
/
Accepted: 30 January 2023
/
Published: 31 January 2023
Abstract
:Predicting the short-term prognosis of patients with terminal cancer is important for treatment decisions and improving patients’ quality of life. Recently, it has been reported that the Barthel Index (BI) can predict short-term prognosis. This study aimed to distinguish the BI items that can more accurately predict the short-term prognosis of terminal cancer patients from among the other BI items. This study compared the accuracy of predicting the 1-, 2-, and 3-week prognosis of BI and individual BI items in 158 cancer patients who died between January 2018 and June 2020 at the Onomichi Municipal Hospital in Japan. For predicting the 1- and 2-week prognosis, the BI item “feeding” scores of 0/5 and 10 showed higher accuracies (0.766 and 0.715, respectively) than BI scores between 0–15/20–100. For predicting a 3-week prognosis, the BI item “mobility” scores of 0, 5/10, 15 and the BI item “grooming” scores between 0/5 showed higher accuracies (0.627 and 0.614, respectively) than BI scores between 0–35/40–100. BI and individual BI items may be an option for prognostic prediction in terminal cancer patients.
1. Introduction
Terminal cancer patients and their families want prognostic information [1]. In addition, information about prognostic predictions for terminal cancer patients is helpful for medical staff to provide optimal treatment [2,3]. To estimate the short–term prognosis of patients with terminal cancer, it is important to develop prognostic indicators that do not require blood tests [4].
The Barthel Index (BI) is a commonly used Activities of Daily Living (ADL) index [5]. Godfrey et al. reported that determining the Barthel score on admission can predict a short prognosis in palliative care patients [6]. We reported that the BI might be more useful as a prognostic indicator than the Glasgow Prognostic Score in terminal cancer patients [7]. Further, we reported the relationship differences between individual components of the BI and the mortality of terminal cancer patients [8]. It was considered that some BI items were more suitable for short-term prognosis prediction, while others were unsuitable for short-term prognosis prediction in patients requiring palliative care.
To the best of our knowledge, this is the first study to explore BI and individual BI items as short–term prognosis indicators for patients with terminal cancer. Therefore, the aim of this study was to identify BI items that can more accurately predict the short-term prognosis of terminal cancer patients from among the BI items.
2. Materials and Methods
2.1. Patients
We retrospectively analyzed information on patients with cancer as their primary diagnosis who died while hospitalized at Onomichi Municipal Hospital in Japan from January 2018 to June 2020. Patients with cancer as their primary diagnosis were determined using the Diagnosis Procedure Combination claims database. The background of the patients was investigated with respect to age, sex, primary cancer, and duration between admission and death.
2.2. BI evaluation Methods
The BI is one of the most widely used ADL measures for independence. The BI consists of 10 items: feeding, mobility, grooming, toilet use, bathing, transfer, stairs, dressing, bowels, and bladder, which uses an ordinal rating scale (0, 5, 10, or 15) to give a total possible score of 0 to 100 [5]. To investigate the predictive accuracy of the BI, we divided the BI into five groups by score: “BI 0–15,” “BI 20–35,” “BI 40–55,” “BI 60–75,” and “BI 80–100” [9].
2.3. Predictive Performance
This study aimed to investigate the predictive accuracy of BI and individual BI items at admission. Thus, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for predicting 1-, 2- and 3-week prognosis of BI and BI items at hospitalization were calculated (Figure 1). Accuracy was calculated by dividing the sum of the true positive and true negative cases by the total number of cases.
2.4. Statistical Analysis
Cutoff values for prognosis prediction were set by the plot of a receiver operating characteristic curve with the highest Youden index for BI and individual BI items. Survival or death within 1, 2, and 3 weeks of admission was defined as dependent items, and BI and BI items were defined as independent items.
Statistical analyses were performed using EZR version 1.40 (Saitama Medical Center, Jichi Medical University, Saitama, Japan) [10].
With reference to Baba et al., we calculated the required sample size. The sample size was assumed to be a minimum 150 patients, with all study results required to calculate an accuracy within 15% width at 95% confidence intervals for a value of 70% [11].
3. Results
A total of 165 patients were enrolled, and 158 were selected after excluding 7 with missing BI data. Characteristics are shown in Table 1. The median (25–75% interquartile range (IQR)) age was 79 (71–85) years. The proportions of men and women were 66.5% and 33.5%, respectively. The median (IQR) duration from admission to death was 20 days (range: 10–37 days).
Table 2 shows the sensitivity, specificity, PPV, NPV, and accuracy of the BI and individual BI items. For predicting 1-week prognosis, using a range of BI scores between 0–15/20–100 demonstrated accuracy (0.633). For predicting 2-week prognosis, using a range of BI scores between 0–15/20–100 demonstrated accuracy (0.633). For predicting 3-week prognosis, using a range of BI scores between 0–35/40–100 demonstrated accuracy (0.608). For predicting 1- and 2-week prognosis, the BI item “feeding” score between 0/5, 10 showed higher accuracy (0.766 and 0.715, respectively) than the range of BI scores between 0–15/20–100. Furthermore, for predicting 3-week prognosis, the BI item “mobility” scores between 0, 5/10, 15 and the BI item “grooming” scores between 0/5 showed higher accuracy (0.627 and 0.614, respectively) than BI scores between 0–35/40–100.
4. Discussion
Godfrey et al. and Bennett et al. and our previous studies have shown that decreased BI score is an important prognostic indicator [6,7,8,12]. From these reports, we hypothesized that a decrease in a specific BI item score may have an effect on the BI score decrease.
This study revealed the characteristics of individual BI items as short–term prognostic indicators for terminal cancer patients. The results of this study suggest that the BI item “feeding” can better predict 1- or 2-week prognosis for terminal cancer patients than BI. Moreover, it is suggested that the BI item “mobility” and “grooming” can be better predictors of 3-week prognosis in terminally ill cancer patients than BI.
In this study, the BI was scored by nurses. Because this was a retrospective study, the time required for BI scoring could not be ascertained. Anyone can easily evaluate BI by learning the measurement method from a manual (https://www.sralab.org/sites/default/files/2017-07/barthel.pdf, accessed on 29 December 2022.). It has been reported that the BI can be scored in an average of 2.2 minutes per patient and is very easy to use [13,14]. Scoring only some items of the BI is even easier than scoring the BI. In these respects as well, prognosis prediction using some items of BI is considered to be more useful.
Chow et al. reported that routine blood tests are not recommended in terminal cancer patients [4]. Performance status (PS), oral intake, dyspnea, and delirium have been reported as prognostic factors that do not require blood testing [15,16]. Validated prognostic tools that do not require blood tests include Palliative Prognostic Index (PPI) [17,18,19,20,21], and Performance Status–Based Palliative Prognostic Index (PS-PPI) [22]. The PPI is calculated by PS based on the Palliative Performance Scale (PPS) [23], oral intake, edema, dyspnea at rest, and delirium. Also, the PS of the PS-PPI is based on the Eastern Cooperative Oncology Group PS [24]. The PPI and PS-PPI are calculated by summing the PS score and several symptom scores. From the above, prognosis prediction using only a few items of BI may be much easier than prognosis prediction using the PPI and PS-PPI.
This study has some limitations. First, it was a retrospective study. Second, our study was performed at a single facility. Thus, the results of our study cannot be generalized. Therefore, a prospective multicenter validation study is needed in the future.
5. Conclusions
As a simple short-term prognostic method for terminal cancer patients that does not require a blood test, we reported on a survey that focused on BI items. The use of BI items such as “feeding”, “mobility” and “grooming” is worthwhile for predicting short-term prognosis in terminal cancer patients.
Author Contributions
S.O., K.O. and M.O. conceived and designed this study. S.O. and K.O. collected the data and K.O. and M.O. analyzed the data. F.M., Y.H., Y.O., K.B., H.S., E.T., S.T. and N.S. supervised the conduct of this study. S.O., K.O. and M.O. drafted the manuscript, and all authors contributed to its revision. All authors have read and approved the final version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
This study was approved by the research ethics committee of Onomichi Municipal Hospital (approval number 20–23).
Informed Consent Statement
Informed consent was obtained in the form of opt–out on the web–site. The content of comprehensive informed consent has been disclosed information on the website on Onomichi Municipal Hospital (http://www.onomichi-hospital.jp/privacypolicy/, accessed on 30 January 2023) and posted in Onomichi Municipal Hospital.
Data Availability Statement
The data presented in this study are available upon request from the corresponding author (Masahiro Okada).
Acknowledgments
We are grateful to Tomohiro Hosokawa and Nana Morio for helpful discussions.
Conflicts of Interest
The authors have no conflict of interest.
References
- Steinhauser, K.E.; Christakis, N.A.; Clipp, E.C.; McNeilly, M.; McIntyre, L.; Tulsky, J.A. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000, 284, 2476–2482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Niki, K.; Okamoto, Y.; Matano, Y.; Ishii, R.; Matsuda, Y.; Takagi, T.; Uejima, E. Validation of a short–term, objective, prognostic predictive method for terminal cancer patients in a palliative care unit using a combination of six laboratory test items. J. Palliat. Med. 2019, 22, 685–690. [Google Scholar] [CrossRef] [PubMed]
- Morita, T.; Tei, Y.; Inoue, S. Correlation of the dose of midazolam for symptom control with administration periods: The possibility of tolerance. J. Pain Symptom Manag. 2003, 25, 369–375. [Google Scholar] [CrossRef] [PubMed]
- Chow, E.; Harth, T.; Hruby, G.; Finkelstein, J.; Wu, J.; Danjoux, C. How accurate are physicians’ clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients?—A systematic review. Clin. Oncol. 2001, 13, 209–218. [Google Scholar] [CrossRef]
- Mahoney, F.I.; Barthel, D.W. Functional evaluation: The Barthel Index. Maryland. State. Mad. J. 1965, 14, 61–65. [Google Scholar]
- Godfrey, J.; Poole, L. An audit of the use of the Barthel Index in palliative care. Int. J. Palliat. Nurs. 2007, 13, 543–548. [Google Scholar] [CrossRef] [PubMed]
- Okada, M.; Okazaki, K.; Murakami, F.; Okamoto, S.; Sugihara, H.; Banshoya, K.; Onoda, T.; Takei, E.; Takeda, S.; Sugihara, N. Examination of a Short–Term, Prognostic Predictive Method for Terminal Cancer Patients Using the Barthel Index. Reports 2020, 3, 26. [Google Scholar] [CrossRef]
- Okada, M.; Okazaki, K.; Murakami, F.; Okamoto, S.; Sugihara, H.; Hoshino, Y.; Goto, Y.; Banshoya, K.; Kimura, K.; Onoda, T.; et al. The Relationship between Components of the Barthel Index and Mortality of Terminal Cancer Patients. Iryo Yakugaku (Jpn. J. Pharm. Health Care Sci.) 2019, 45, 605–609. [Google Scholar] [CrossRef]
- Sinoff, G.; Ore, L. The Barthel activities of daily living index: Self–reporting versus actual performance in the old–old (> or = 75 years). J. Am. Geriatr. Soc. 1997, 45, 832–836. [Google Scholar] [CrossRef] [PubMed]
- Kanda, Y. Investigation of the freely available easy–to–use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013, 48, 452–458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baba, M.; Maeda, I.; Morita, T.; Inoue, S.; Ikenaga, M.; Matsumoto, Y.; Sekine, R.; Yamaguchi, T.; Hirohashi, T.; Tajima, T.; et al. Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium–Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model. Eur. J. Cancer 2015, 51, 1618–1629. [Google Scholar] [CrossRef] [PubMed]
- Bennett, M.; Ryall, N. Using the modified Barthel index to estimate survival in cancer patients in hospice: Observational study. BMJ 2000, 321, 1381–1382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelly, S.; Jessop, E.G. A comparison of measures of disability and health status in people with physical disabilities undergoing vocational rehabilitation. J. Public Health 1996, 18, 169–174. [Google Scholar] [CrossRef] [PubMed]
- Disease, P.V.; Kodama, A.; Koyama, A.; Sugimoto, M.; Niimi, K.; Banno, H.; Komori, K. Association Between Preoperative Frailty and Mortality in Patients With Critical Limb Ischemia Following Infrainguinal Bypass Surgery―Usefulness of the Barthel Index―. Circ. J. 2018, 82, 267–274. [Google Scholar] [CrossRef] [Green Version]
- Maltoni, M.; Caraceni, A.; Brunelli, C.; Broeckaert, B.; Christakis, N.; Eychmueller, S.; Glare, P.; Nabal, M.; Vigano, A.; Larkin, P.; et al. Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations—A study by the steering committee of the european association for palliative care. J. Clin. Oncol. 2005, 23, 6240–6248. [Google Scholar] [CrossRef] [PubMed]
- Lau, F.; Cloutier-Fisher, D.; Kuziemsky, C.; Black, F.; Downing, M.; Borycki, E.; Ho, F. A Systematic Review of Prognostic Tools for Estimating Survival Time in Palliative Care. J. Palliat Care 2007, 23, 93–112. [Google Scholar] [CrossRef]
- Morita, T.; Tsunoda, J.; Inoue, S.; Chihara, S. The Palliative Prognostic Index: A scoring system for survival prediction of terminally ill cancer patients. Support. Care Cancer 1999, 7, 128–133. [Google Scholar] [CrossRef] [PubMed]
- Morita, T.; Tsunoda, J.; Inoue, S.; Chihara, S. Improved accuracy of physicians’ survival prediction for terminally ill cancer patients using the Palliative Prognostic Index. Palliat. Med. 2001, 15, 419–424. [Google Scholar] [CrossRef] [PubMed]
- Hui, D.; Paiva, C.E.; Del Fabbro, E.G.; Steer, C.; Naberhuis, J.; van de Wetering, M.; Fernández-Ortega, P.; Morita, T.; Suh, S.Y.; Bruera, E.; et al. Prognostication in advanced cancer: Update and directions for future research. Support. Care Cancer 2019, 27, 1973–1984. [Google Scholar] [CrossRef] [PubMed]
- Hui, D.; Maxwell, J.P.; Paiva, C.E. Dealing with prognostic uncertainty: The role of prognostic models and websites for patients with advanced cancer. Curr. Opin. Support. Palliat. Care 2019, 13, 360–368. [Google Scholar] [CrossRef] [PubMed]
- Iizuka-Honma, H.; Mitsumori, T.; Yoshikawa, S.; Takizawa, H.; Noguchi, M. Prognostic Value of Palliative Prognostic Index for Hospitalized Patients With End-of-Life Hematologic Malignancies in a Japanese University Hospital. JCO Oncol. Pract. 2022, 18, e108–e116. [Google Scholar] [CrossRef] [PubMed]
- Yamada, T.; Morita, T.; Maeda, I.; Inoue, S.; Ikenaga, M.; Matsumoto, Y.; Baba, M.; Sekine, R.; Yamaguchi, T.; Hirohashi, T.; et al. A prospective, multicenter cohort study to validate a simple performance status–based survival prediction system for oncologists. Cancer 2017, 123, 1442–1452. [Google Scholar] [CrossRef] [PubMed]
- Anderson, F.; Downing, G.M.; Hill, J.; Casorso, L.; Lerch, N. Palliative Performance Scale (PPS): A new tool. J. Palliat. Care 1996, 12, 5–11. [Google Scholar] [CrossRef] [PubMed]
- Oken, M.M.; Creech, R.H.; Davis, T.E. Toxicology and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. Cancer Clin. Trials 1982, 5, 649–655. [Google Scholar]
Figure 1.
The procedure for evaluating the prognostic accuracy of BI in patients with terminal cancer. (Abbreviations: BI, Barthel index.)
Figure 1.
The procedure for evaluating the prognostic accuracy of BI in patients with terminal cancer. (Abbreviations: BI, Barthel index.)
Table 1.
Characteristics of the patients in this study.
| Characteristic | Findings |
|---|---|
| N | 158 |
| Age (years) | 79 (71–85) |
| Sex (men/women), n (%) | 105/53 (66.5/33.5) |
| Primary cancer, n (%) | |
| Colorectal | 25 (15.8) |
| Lung malignant mesothelioma | 21 (13.3) |
| Gastric | 21 (13.3) |
| Liver | 17 (10.8) |
| Pancreatic | 15 (9.5) |
| Biliary Tract | 14 (8.9) |
| Blood | 12 (7.6) |
| Brain | 8 (5.1) |
| Prostate | 5 (3.2) |
| Bladder | 5 (3.2) |
| Others | 15 (9.5) |
| Duration between admission and death (days) | 20 (10–37) |
Data are median (25–75% interquartile range) or percentage.
Table 2.
Sensitivity, specificity, PPV, NPV, accuracy of BI and BI items.
| Item | Cutoff Value | Sensitivity | Specificity | PPV | NPV | Accuracy | |
|---|---|---|---|---|---|---|---|
| 1-week | BI | 0–15/20–100 | 0.667 | 0.627 | 0.242 | 0.913 | 0.633 |
| Feeding | 0/5,10 | 0.625 | 0.791 | 0.349 | 0.922 | 0.766 | |
| Mobility | 0,5/10,15 | 0.833 | 0.507 | 0.233 | 0.944 | 0.557 | |
| Grooming | 0/5 | 0.875 | 0.276 | 0.178 | 0.925 | 0.367 | |
| Toilet use | 0/5,10 | 0.750 | 0.575 | 0.240 | 0.928 | 0.601 | |
| Bathing | 0/5 | 0.958 | 0.179 | 0.173 | 0.960 | 0.297 | |
| Transfer | 0/5,10,15 | 0.833 | 0.448 | 0.213 | 0.938 | 0.506 | |
| Stairs | 0/5,10 | 0.792 | 0.321 | 0.173 | 0.896 | 0.392 | |
| Dressing | 0/5,10 | 0.792 | 0.463 | 0.209 | 0.925 | 0.513 | |
| Bowels | 0/5,10 | 0.667 | 0.567 | 0.216 | 0.905 | 0.582 | |
| Bladder | 0/5,10 | 0.667 | 0.575 | 0.219 | 0.906 | 0.589 | |
| 2-week | BI | 0–15/20–100 | 0.571 | 0.667 | 0.485 | 0.739 | 0.633 |
| Feeding | 0/5,10 | 0.482 | 0.843 | 0.628 | 0.748 | 0.715 | |
| Mobility | 0,5/10,15 | 0.732 | 0.559 | 0.477 | 0.792 | 0.620 | |
| Grooming | 0/5 | 0.821 | 0.294 | 0.390 | 0.750 | 0.481 | |
| Toilet use | 0/5,10 | 0.607 | 0.598 | 0.453 | 0.735 | 0.601 | |
| Bathing | 0/5 | 0.893 | 0.186 | 0.376 | 0.760 | 0.437 | |
| Transfer | 0/5,10,15 | 0.714 | 0.471 | 0.426 | 0.750 | 0.557 | |
| Stairs | 0/5,10 | 0.821 | 0.373 | 0.418 | 0.792 | 0.532 | |
| Dressing | 0/5,10 | 0.661 | 0.471 | 0.407 | 0.716 | 0.538 | |
| Bowels | 0/5,10 | 0.589 | 0.598 | 0.446 | 0.726 | 0.595 | |
| Bladder | 0/5,10 | 0.571 | 0.598 | 0.438 | 0.718 | 0.589 | |
| 3-week | BI | 0–35/40–100 | 0.694 | 0.507 | 0.621 | 0.587 | 0.608 |
| Feeding | 0,5/10 | 0.647 | 0.521 | 0.611 | 0.559 | 0.589 | |
| Mobility | 0,5/10,15 | 0.659 | 0.589 | 0.651 | 0.597 | 0.627 | |
| Grooming | 0/5 | 0.835 | 0.356 | 0.602 | 0.650 | 0.614 | |
| Toilet use | 0,5/10 | 0.859 | 0.315 | 0.593 | 0.657 | 0.608 | |
| Bathing | 0/5 | 0.894 | 0.219 | 0.571 | 0.640 | 0.582 | |
| Transfer | 0/5,10,15 | 0.682 | 0.507 | 0.617 | 0.578 | 0.601 | |
| Stairs | 0/5,10 | 0.776 | 0.397 | 0.600 | 0.604 | 0.601 | |
| Dressing | 0/5,10 | 0.659 | 0.521 | 0.615 | 0.567 | 0.595 | |
| Bowels | 0,5/10 | 0.682 | 0.493 | 0.611 | 0.571 | 0.595 | |
| Bladder | 0,5/10 | 0.706 | 0.466 | 0.606 | 0.576 | 0.595 |
Abbreviations: BI, Barthel index; PPV, positive predictive value; NPV, negative predictive value. The optimal prognostic cutoff values for the BI and individual BI items were determined by plotting a receiver operating characteristic curve with the highest Youden index among all possible cutoff values.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Okamoto, S.; Okazaki, K.; Okada, M.; Murakami, F.; Sugihara, H.; Hoshino, Y.; Ogawa, Y.; Banshoya, K.; Takei, E.; Takeda, S.; et al. The Relationship between the Items of the Barthel Index and Short-Term Prognosis in Terminal Cancer Patients. Reports 2023, 6, 5. https://doi.org/10.3390/reports6010005
AMA Style
Okamoto S, Okazaki K, Okada M, Murakami F, Sugihara H, Hoshino Y, Ogawa Y, Banshoya K, Takei E, Takeda S, et al. The Relationship between the Items of the Barthel Index and Short-Term Prognosis in Terminal Cancer Patients. Reports. 2023; 6(1):5. https://doi.org/10.3390/reports6010005
Chicago/Turabian StyleOkamoto, Shinya, Kazuko Okazaki, Masahiro Okada, Fumiyoshi Murakami, Hiroki Sugihara, Yoshinori Hoshino, Yuka Ogawa, Kengo Banshoya, Eisuke Takei, Shuso Takeda, and et al. 2023. "The Relationship between the Items of the Barthel Index and Short-Term Prognosis in Terminal Cancer Patients" Reports 6, no. 1: 5. https://doi.org/10.3390/reports6010005
